Effect of Baclofen in Management of Patients With Gastroesophageal Reflux Disease Symptoms
Recruiting
Phase 2
Phase 3
Interventional Study
GERD - PPI Non-responders
Pivotal Trial
This treatment is in the last trial phase before FDA approval.
Prior Safety Data
This treatment has already been tested in at least one earlier human trial.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 2/3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 60 (estimated)
- Sponsor
- Adnan Imtiaj Rahul · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
The goal of this clinical trial is to assess the effect of using baclofen along with conventional treatment in improving GERD symptoms. It will also assess the safety of drug baclofen by recording the patient reported adverse events. The main questions it aims to answer are :
Does drug baclofen along with conventional treatment has any effect on patients with GERD symptoms? What medical problems …
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Age 18 and above
* Patients with persistent GERD symptoms (Heart burn and/or regurgitation) despite taking conventional treatment including PPI for 8 weeks
Exclusion Criteria:
* GERD symptoms with any alarming features (dysphagia, weight loss, bleeding, vomiting, and/or anem…
Contacts